KOKO - the company >> news imprint sitemap German
 
welcome
news
products
publications
skin topics
corneotherapy
mediathek
skin testing
trade fairs & trainings
KOKO - the company
news
arrival
purchase
gallery
imprint
partners
service
 
Suche - Search
 
  New medicinal product
 

Our global partner, High Grade Pharmaceutical Co., Ltd., has applied for a patent "Drugs having Steroids and Fatty Compounds" in Taiwan, China und USA at the beginning of the year 2017. The first product of the patent, based on DMS® technology and Fluticasone Propionate (INN), a pharmaceutical drug similar to hydrocortisone, was developed with KOKO and launched in Taiwan recently. Among others it is recommended for acute, inflamed cases of neurodermatitis. Advantage: After fast remission of the skin reactions the treatment can be continued subsequently by cosmetic prevention, e.g. with DMS® base cream High Classic Plus. For the first time pharmaceutical treatment is combined with sustained corneotherapy by means of lamellar creams.

Lamellar Fluticasone cream

Lamellar Fluticasone cream

 
       
 
 
 
Kindly inform us at koko@dermaviduals.de if you have found any misprint or any other relevant mistake on this page

© Copyright Kosmetik Konzept KOKO GmbH & Co. KG, Leichlingen, www.dermaviduals.de
Revision: 29.09.2017